IPSC vs MTB · rev $6.6M vs P/E 12, $30.99B cap
Century Therapeutics Inc (IPSC) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
MTB does not have a complete income-statement cache yet.
IPSC currently screens at market cap $47.8M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the IPSC and MTB stock pages for the full models.
Not investment advice.